![Daljit Singh Aurora](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daljit Singh Aurora
Directeur des opérations chez
NEUMORA THERAPEUTICS, INC.
Fortune : 78 488 $ au 31/07/2026
Profil
Daljit Singh Aurora is currently Chief Operating & Development Officer at Neumora Therapeutics, Inc. since 2025.
Former positions include Chief Scientific Affairs Officer at Dermira, Inc. from 2019 to 2021, Vice President-Medical Affairs at Neurocrine Biosciences, Inc. from 2015 to 2016, Vice President-Scientific Affairs at Merck Research Laboratories Massachusetts LLC from 2014 to 2015, and VP-Worldwide Compliance & Business Ethics at Amgen, Inc. from 2013 to 2014.
Education includes undergraduate studies at The University of Texas at Austin and a doctorate from The University of Texas Health Science Center at Houston.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/08/2026 | 48 750 ( 0,03% ) | 78 488 $ | 31/07/2026 |
Postes actifs de Daljit Singh Aurora
| Sociétés | Poste | Début |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Directeur des opérations | 14/02/2025 |
Anciens postes connus de Daljit Singh Aurora
| Sociétés | Poste | Fin |
|---|---|---|
| DERMIRA, INC. | Compliance Officer | 01/11/2019 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/07/2016 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | 01/04/2015 |
| AMGEN INC. | Corporate Officer/Principal | 01/09/2014 |
Formation de Daljit Singh Aurora
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
The University of Texas Health Science Center at Houston
 The University of Texas Health Science Center at Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
